Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Drug Combination Details

General Information of the Combination (ID: C48863)
Name Juglans regia   NP Info  + Oxacillin   Drug Info 
Structure +
Disease
Staphylococcus infection [ICD-11: 1C41]
Investigative [1]
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. Enhancing Drug Efficacy by This Combination
                 Achieving Therapeutic Synergy     Click to Show/Hide
                    Experiment 1 Reporting the Effect of This Combination [1]
                    In-vitro Model Staphylococcus aureus Microorganism model Staphylococcus aureus
Streptococcus pyogenes Microorganism model Streptococcus pyogenes
Escherichia coli Microorganism model Escherichia coli
Salmonella enterica serovar Typhi Microorganism model Salmonella enterica
Shigella species Microorganism model Shigella
Salmonella Paratyphi A Microorganism model Salmonella Paratyphi
Pseudomonas aeuginosa Microorganism model Pseudomonas aeruginosa
Acinetobacter baumannii Microorganism model Acinetobacter baumannii
Klebseilla pneumoniae Microorganism model Klebseilla pneumoniae
Citrobacter freuendii Microorganism model Citrobacter freuendii
Enterobacter cloacae Microorganism model Enterobacter cloacae
Bacillus subtilis Microorganism model Bacillus subtilis
Streptococcus pneumoniae Microorganism model Streptococcus pneumoniae
Micrococcus Microorganism model Micrococcus
Helicobacter pylori Microorganism model Helicobacter pylori
Campylobacter jejuni Microorganism model Campylobacter jejuni
Pasteurella multocida Microorganism model Pasteurella multocida
                    Experimental
                    Result(s)
Ten times reduction in MICs was observed against Staphylococcus aureus when used in combination with oxacillin.
References
Reference 1 Synergistic antimicrobial activity of Camellia sinensis and Juglans regia against multidrug-resistant bacteria. PLoS One. 2015 Feb 26;10(2):e0118431.
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China